Latest Breaking News On - Hubei biocause phamaceutical co ltd - Page 1 : comparemela.com

The global ibuprofen API market surpassed US$ 572.9 Mn in 2019 and is set for a stable growth outlook over the course of 2019 – 2029, as per the findings of a new Future Market Insights (FMI) study. The primary factors for growth of the Ibuprofen API market include continuous demand for low-cost non-steroidal anti-i.

United arab emiratesUnited statesUnited kingdomHubei biocause phamaceutical co ltdHubei biocause heilen pharmaceutical coContract manufacturing organizationGsi group incHealthcare division at future market insightsSino us zibo xinhua perrigo pharmaceutical co ltdGranules india ltdSolara active pharma sciencesFuture market insightsNorth americaContract manufacturing organizationsSouth asiaStrategic mergers